Amalgamated Bank’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,270
| Closed | -$24K | – | 3203 |
|
|
2022
Q1 | $24K | Sell |
1,270
-104
| -8% | -$1.64K | ﹤0.01% | 2746 |
|
|
2021
Q4 | $24K | Buy |
1,374
+23
| +2% | +$689 | ﹤0.01% | 2139 |
|
|
2021
Q3 | $50K | Sell |
1,351
-15
| -1% | -$666 | ﹤0.01% | 2134 |
|
|
2021
Q2 | $81K | Buy |
1,366
+687
| +101% | +$41.6K | ﹤0.01% | 2130 |
|
|
2021
Q1 | $46K | Hold |
679
| – | – | ﹤0.01% | 1583 |
|
|
2020
Q4 | $41K | Hold |
679
| – | – | ﹤0.01% | 1568 |
|
|
2020
Q3 | $54K | Sell |
679
-16
| -2% | -$1.27K | ﹤0.01% | 1453 |
|
|
2020
Q2 | $43K | Sell |
695
-55
| -7% | -$3.2K | ﹤0.01% | 1454 |
|
|
2020
Q1 | $40K | Sell |
750
-24
| -3% | -$2.38K | ﹤0.01% | 1586 |
|
|
2019
Q4 | $94K | Buy |
774
+127
| +20% | +$18.3K | ﹤0.01% | 1741 |
|
|
2019
Q3 | $117K | Sell |
647
-5
| -0.8% | -$705 | ﹤0.01% | 1639 |
|
|
2019
Q2 | $85K | Buy |
652
+105
| +19% | +$18.8K | ﹤0.01% | 1708 |
|
|
2019
Q1 | $133K | Buy |
547
+21
| +4% | +$5.56K | ﹤0.01% | 1577 |
|
|
2018
Q4 | $100K | Buy |
526
+311
| +145% | +$75.9K | ﹤0.01% | 1525 |
|
|
2018
Q3 | $70K | Sell |
215
-301
| -58% | -$92.2K | ﹤0.01% | 1406 |
|
|
2018
Q2 | $161K | Buy |
516
+71
| +16% | +$21.7K | ﹤0.01% | 1610 |
|
|
2018
Q1 | $108K | Sell |
445
-8
| -2% | -$2.24K | ﹤0.01% | 1528 |
|
|
2017
Q4 | $137K | Buy |
453
+54
| +14% | +$15K | ﹤0.01% | 1556 |
|
|
2017
Q3 | $105K | Buy |
399
+4
| +1% | +$1.16K | ﹤0.01% | 1511 |
|
|
2017
Q2 | $104K | Buy |
395
+27
| +7% | +$6.76K | ﹤0.01% | 1514 |
|
|
2017
Q1 | $133K | Sell |
368
-1
| -0.3% | -$309 | 0.01% | 1427 |
|
|
2016
Q4 | $106K | Buy |
369
+51
| +16% | +$15.8K | ﹤0.01% | 1455 |
|
|
2016
Q3 | $108K | Hold |
318
| – | – | 0.01% | 1329 |
|
|
2016
Q2 | $115K | Buy |
318
+15
| +5% | +$6.18K | 0.01% | 1328 |
|
|
2016
Q1 | $97K | Buy |
303
+59
| +24% | +$20.1K | 0.01% | 1225 |
|
|
2015
Q4 | $127K | Sell |
244
-24
| -9% | -$8.86K | 0.02% | 1134 |
|
|
2015
Q3 | $78K | Buy |
268
+5
| +2% | +$1.78K | 0.01% | 1251 |
|
|
2015
Q2 | $103K | Buy |
263
+26
| +11% | +$9.17K | 0.01% | 1303 |
|
|
2015
Q1 | $72K | Buy |
237
+28
| +13% | +$6.83K | 0.01% | 916 |
|
|
2014
Q4 | $46K | Buy |
+209
| New | +$43.1K | 0.01% | 841 |
|
Other funds holding TXMD
RCMNY
E
GF
Amalgamated Bank's TXMD Position: Q2 2022 in Review
Amalgamated Bank sold out of TherapeuticsMD (TXMD) in Q2 2022, closing a stake of 1,270 shares — an estimated $24K sold.
Amalgamated Bank first reported a position in TXMD in Q4 2014 and held it in 30 quarters. The position peaked at $161K in Q2 2018. 53 funds tracked by Wall St. Rank hold TXMD as of Q2 2022.
- Amalgamated Bank reported no remaining TherapeuticsMD position as of Q2 2022 after selling out during the quarter.
- Amalgamated Bank sold 1,270 TherapeuticsMD shares in Q2 2022, an estimated $24K.
- Amalgamated Bank first reported a position in TherapeuticsMD in Q4 2014 and held it in 30 quarters.
- Amalgamated Bank's TherapeuticsMD position peaked at $161K in Q2 2018.
- 53 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2022.
Based on Amalgamated Bank's 13F filing for Q2 2022, filed 15 Aug 2022.